×

DJ: Valeant & Pershing to boost Allergan bid

5:58 PM ET Tue, 7 Oct 2014

Dow Jones is reporting citing sources that Valeant and Pershing Square plan to boost their bid for Allergan by around $15 per share. CNBC's Dominic Chu has the details.